Background: First results of Trilège demonstrated that the strategy of less intensive antiviral therapy is less effective than continuation of triple-drug therapy.
Objective: To compare the final number of failures at month 18 and to study viral dynamics in patients experiencing a virological failure.
Design: Longitudinal follow-up from a randomized controlled trial.